Nuo Therapeutics Inc
Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. It serves hospita… Read more
Nuo Therapeutics Inc (AURX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.318x
Based on the latest financial reports, Nuo Therapeutics Inc (AURX) has a cash flow conversion efficiency ratio of -0.318x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($262.37K) by net assets ($-824.56K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nuo Therapeutics Inc - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Nuo Therapeutics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nuo Therapeutics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nuo Therapeutics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
I GRANDI VIAGGI
F:95H
|
N/A |
|
Bioptik Technology
TWO:4161
|
0.038x |
|
Bohae Brewery
KO:000890
|
0.023x |
|
Elixir Energy Limited
PINK:ELXPF
|
-0.049x |
|
Premium Catering (Holdings) Limited
NASDAQ:PC
|
N/A |
|
SEOWONINTECH.Co.Ltd
KQ:093920
|
0.008x |
|
WIZIT Co. Ltd
KQ:036090
|
-0.015x |
|
Pacific Valley Bank
PINK:PVBK
|
0.003x |
Annual Cash Flow Conversion Efficiency for Nuo Therapeutics Inc (2014–2024)
The table below shows the annual cash flow conversion efficiency of Nuo Therapeutics Inc from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $513.71K | $-2.23 Million | -4.344x | -42.50% |
| 2023-12-31 | $1.04 Million | $-3.17 Million | -3.048x | -80.25% |
| 2022-12-31 | $2.19 Million | $-3.71 Million | -1.691x | -836.73% |
| 2021-12-31 | $-522.54K | $-119.95K | 0.230x | +120.00% |
| 2020-12-31 | $-515.79K | $-53.82K | 0.104x | -94.23% |
| 2019-12-31 | $-509.24K | $-921.67K | 1.810x | -83.03% |
| 2018-12-31 | $-81.99K | $-874.39K | 10.665x | +205.01% |
| 2017-12-31 | $482.87K | $-4.90 Million | -10.156x | -1060.54% |
| 2016-12-31 | $12.49 Million | $-10.93 Million | -0.875x | -322.24% |
| 2015-12-31 | $-36.56 Million | $-14.39 Million | 0.394x | +134.96% |
| 2014-12-31 | $15.47 Million | $-17.42 Million | -1.126x | -- |